| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Axitinib | FIMM | pan-cancer | AAC | 0.52 | 0.0002 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.092 | 0.002 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.004 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.005 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.15 | 0.005 |
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | -0.11 | 0.005 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.097 | 0.007 |